Apparent interference with extracorporeal membrane oxygenation by liposomal amphotericin B in a patient with disseminated blastomycosis receiving continuous renal replacement therapy.
CONCLUSION: In our case we believe that liposomal amphotericin B was significantly removed by ECMO and was responsible for the failure of the ECMO circuit. We would suggest amphotericin B deoxycholate be used in such patients preferentially and that serum levels of the drug be assessed when possible.
PMID: 30994894 [PubMed - as supplied by publisher]
Source: American Journal of Health-System Pharmacy : AJHP - Category: Drugs & Pharmacology Authors: Branick K, Taylor MJ, Trump MW, Wall GC Tags: Am J Health Syst Pharm Source Type: research
More News: Abelcet | American Health | Bronchoscopy | Cough | Dialysis | Drugs & Pharmacology | Hemodialysis | Respiratory Medicine | Tracheostomy | Trump | Urology & Nephrology | USA Health